TY - JOUR
T1 - L-glutamate released from activated microglia downregulates astrocytic L-glutamate transporter expression in neuroinflammation
T2 - The 'collusion' hypothesis for increased extracellular L-glutamate concentration in neuroinflammation
AU - Takaki, Junpei
AU - Fujimori, Koki
AU - Miura, Marie
AU - Suzuki, Takeshi
AU - Sekino, Yuko
AU - Sato, Kaoru
N1 - Funding Information:
This study was partly supported by a Grant-in-Aid from the Food Safety Commission of Japan (No. 1003); a Grant-in-Aid for Young Scientists from MEXT, Japan (KAKENHI 21700422); the Program for the Promotion of Fundamental Studies in Health Sciences of NIBIO, Japan; a Health and Labor Science Research Grant for Research on Risks of Chemicals; and a Health and Labor Science Research Grant for Research on New Drug Development from MHLW, Japan, awarded to KS and YS.
PY - 2012/12/23
Y1 - 2012/12/23
N2 - Background: In the central nervous system, astrocytic L-glutamate (L-Glu) transporters maintain extracellular L-Glu below neurotoxic levels, but their function is impaired with neuroinflammation. Microglia become activated with inflammation; however, the correlation between activated microglia and the impairment of L-Glu transporters is unknown.Methods: We used a mixed culture composed of astrocytes, microglia, and neurons. To quantify L-Glu transporter function, we measured the extracellular L-Glu that remained 30 min after an application of L-Glu to the medium (the starting concentration was 100 μM). We determined the optimal conditions of lipopolysaccharide (LPS) treatment to establish an inflammation model without cell death. We examined the predominant subtypes of L-Glu transporters and the changes in the expression levels of these transporters in this inflammation model. We then investigated the role of activated microglia in the changes in L-Glu transporter expression and the underlying mechanisms in this inflammation model.Results: Because LPS (10 ng/mL, 72 h) caused a significant increase in the levels of L-Glu remaining but did not affect cell viability, we adopted this condition for our inflammation model without cell death. GLAST was the predominant L-Glu transporter subtype, and its expression decreased in this inflammation model. As a result of their release of L-Glu, activated microglia were shown to be essential for the significant decrease in L-Glu uptake. The serial application of L-Glu caused a significant decrease in L-Glu uptake and GLAST expression in the astrocyte culture. The hemichannel inhibitor carbenoxolone (CBX) inhibited L-Glu release from activated microglia and ameliorated the decrease in GLAST expression in the inflammation model. In addition, the elevation of the astrocytic intracellular L-Glu itself caused the downregulation of GLAST.Conclusions: Our findings suggest that activated microglia trigger the elevation of extracellular L-Glu through their own release of L-Glu, and astrocyte L-Glu transporters are downregulated as a result of the elevation of astrocytic intracellular L-Glu levels, causing a further increase of extracellular L-Glu. Our data suggest the new hypothesis that activated microglia collude with astrocytes to cause the elevation of extracellular L-Glu in the early stages of neuroinflammation.
AB - Background: In the central nervous system, astrocytic L-glutamate (L-Glu) transporters maintain extracellular L-Glu below neurotoxic levels, but their function is impaired with neuroinflammation. Microglia become activated with inflammation; however, the correlation between activated microglia and the impairment of L-Glu transporters is unknown.Methods: We used a mixed culture composed of astrocytes, microglia, and neurons. To quantify L-Glu transporter function, we measured the extracellular L-Glu that remained 30 min after an application of L-Glu to the medium (the starting concentration was 100 μM). We determined the optimal conditions of lipopolysaccharide (LPS) treatment to establish an inflammation model without cell death. We examined the predominant subtypes of L-Glu transporters and the changes in the expression levels of these transporters in this inflammation model. We then investigated the role of activated microglia in the changes in L-Glu transporter expression and the underlying mechanisms in this inflammation model.Results: Because LPS (10 ng/mL, 72 h) caused a significant increase in the levels of L-Glu remaining but did not affect cell viability, we adopted this condition for our inflammation model without cell death. GLAST was the predominant L-Glu transporter subtype, and its expression decreased in this inflammation model. As a result of their release of L-Glu, activated microglia were shown to be essential for the significant decrease in L-Glu uptake. The serial application of L-Glu caused a significant decrease in L-Glu uptake and GLAST expression in the astrocyte culture. The hemichannel inhibitor carbenoxolone (CBX) inhibited L-Glu release from activated microglia and ameliorated the decrease in GLAST expression in the inflammation model. In addition, the elevation of the astrocytic intracellular L-Glu itself caused the downregulation of GLAST.Conclusions: Our findings suggest that activated microglia trigger the elevation of extracellular L-Glu through their own release of L-Glu, and astrocyte L-Glu transporters are downregulated as a result of the elevation of astrocytic intracellular L-Glu levels, causing a further increase of extracellular L-Glu. Our data suggest the new hypothesis that activated microglia collude with astrocytes to cause the elevation of extracellular L-Glu in the early stages of neuroinflammation.
KW - Astrocytes
KW - Hemichannel
KW - Inflammation
KW - L-glutamate
KW - Microglia
KW - Transporter
UR - http://www.scopus.com/inward/record.url?scp=84874014729&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84874014729&partnerID=8YFLogxK
U2 - 10.1186/1742-2094-9-275
DO - 10.1186/1742-2094-9-275
M3 - Article
C2 - 23259598
AN - SCOPUS:84874014729
SN - 1742-2094
VL - 9
JO - Journal of Neuroinflammation
JF - Journal of Neuroinflammation
M1 - 784
ER -